Back to top

zacks-consensus-estimate: Archive

Zacks Equity Research

Actuate Therapeutics, Inc. (ACTU) Upgraded to Buy: What Does It Mean for the Stock?

Actuate Therapeutics, Inc. (ACTU) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks Equity Research

Addus HomeCare (ADUS) Upgraded to Buy: Here's What You Should Know

Addus HomeCare (ADUS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Zacks Equity Research

CB Financial Services (CBFV) Moves to Strong Buy: Rationale Behind the Upgrade

CB Financial Services (CBFV) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks Equity Research

What Makes Pan American Silver (PAAS) a New Strong Buy Stock

Pan American Silver (PAAS) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks Equity Research

Spartacus Acquisition (NN) Upgraded to Buy: Here's Why

Spartacus Acquisition (NN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Zacks Equity Research

Kion Group (KIGRY) Upgraded to Buy: Here's What You Should Know

Kion Group (KIGRY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks Equity Research

All You Need to Know About Harmony Gold (HMY) Rating Upgrade to Buy

Harmony Gold (HMY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Zacks Equity Research

All You Need to Know About Cango (CANG) Rating Upgrade to Strong Buy

Cango (CANG) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Zacks Equity Research

Janus Henderson Group (JHG) Upgraded to Buy: Here's What You Should Know

Janus Henderson Group (JHG) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks Equity Research

vTv Therapeutics (VTVT) Upgraded to Buy: Here's What You Should Know

vTv Therapeutics (VTVT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.